These data indicate that metastatic progression was maintained in TMEM261-silenced tumor cells and suggest that primary tumors contrast with metastases in their requirement for intact TMEM261 function, supporting a model of metabolic heterogeneity. The gene discussed is DMAC1; the disease is neoplasm.